pm llorca
pm llorca
professeur de psychiatrie, Université Clermont Auvergne
Verified email at chu-clermontferrand.fr
Title
Cited by
Cited by
Year
Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders
P Robert, CU Onyike, AFG Leentjens, K Dujardin, P Aalten, S Starkstein, ...
European Psychiatry 24 (2), 98-104, 2009
5132009
Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.
WW Fleischhacker, M Eerdekens, K Karcher, G Remington, PM Llorca, ...
The Journal of clinical psychiatry 64 (10), 1250, 2003
3872003
Diagnostic criteria for apathy in clinical practice
E Mulin, E Leone, K Dujardin, M Delliaux, A Leentjens, F Nobili, B Dessi, ...
International journal of geriatric psychiatry 26 (2), 158-165, 2011
2042011
Partial compliance in schizophrenia and the impact on patient outcomes
PM Llorca
Psychiatry research 161 (2), 235-247, 2008
1852008
Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia
P Damier, S Thobois, T Witjas, E Cuny, P Derost, S Raoul, P Mertens, ...
Archives of general psychiatry 64 (2), 170-176, 2007
1842007
Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
PP Derost, L Ouchchane, D Morand, M Ulla, PM Llorca, M Barget, ...
Neurology 68 (17), 1345-1355, 2007
1762007
Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies
HJ Möller, PM Llorca, E Sacchetti, SD Martin, R Medori, E Parellada, ...
International clinical psychopharmacology 20 (3), 121-130, 2005
1712005
Assessment and management of agitation in psychiatry: expert consensus
M Garriga, I Pacchiarotti, S Kasper, SL Zeller, MH Allen, G Vazquez, ...
The world journal of biological psychiatry 17 (2), 86-128, 2016
1702016
Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.
PM Llorca, C Spadone, O Sol, A Danniau, T Bougerol, E Corruble, ...
The Journal of clinical psychiatry 63 (11), 1020-1027, 2002
1652002
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations
European Network of National Networks studying Gene-Environment Interactions ...
Schizophrenia Bulletin 40 (4), 729-736, 2014
1632014
Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications
D Misdrahi, PM Llorca, C Lancon, FJ Bayle
L'Encephale 28 (3 Pt 1), 266-272, 2002
163*2002
Tardive dyskinesias and antipsychotics: a review
PM Llorca, I Chereau, FJ Bayle, C Lancon
European psychiatry 17 (3), 129-138, 2002
1372002
Psychopathological features of a patient population of targets of workplace bullying
G Brousse, L Fontana, L Ouchchane, C Boisson, L Gerbaud, D Bourguet, ...
Occupational medicine 58 (2), 122-128, 2008
1332008
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
PM Llorca, M Abbar, P Courtet, S Guillaume, S Lancrenon, L Samalin
BMC psychiatry 13 (1), 340, 2013
1222013
A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia
T d'Amato, R Bation, A Cochet, I Jalenques, F Galland, E Giraud-Baro, ...
schizophrenia Research 125 (2-3), 284-290, 2011
1152011
Comparison of escitalopram and citalopram efficacy: a meta-analysis
P Auquier, S Robitail, P Llorca, B Rive
International journal of psychiatry in Clinical Practice 7 (4), 259-268, 2003
1112003
Treated incidence of psychotic disorders in the multinational EU-GEI study
HE Jongsma, C Gayer-Anderson, A Lasalvia, D Quattrone, A Mulè, ...
JAMA psychiatry 75 (1), 36-46, 2018
1052018
Efficacy of escitalopram in patients with severe depression: a pooled analysis
PM Llorca, JM Azorin, N Despiegel, P Verpillat
International journal of clinical practice 59 (3), 268-275, 2005
1022005
Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five‐dimensional factor analysis
C Lancon, V Aghababian, PM Llorca, P Auquier
Acta Psychiatrica Scandinavica 98 (5), 369-376, 1998
1011998
The “Functional Remission of General Schizophrenia”(FROGS) scale: development and validation of a new questionnaire
PM Llorca, C Lançon, S Lancrenon, FJ Bayle, H Caci, F Rouillon, ...
Schizophrenia Research 113 (2-3), 218-225, 2009
992009
The system can't perform the operation now. Try again later.
Articles 1–20